Do all peptides work for weight loss and health?

You have probably seen the internet hype claiming that every peptide is a secret miracle that works for everyone, all the time. Scientists are still working on this one — turns out the human body is complicated. Who knew?

While some peptides have stacks of evidence, others are still living in the 'maybe' pile. Let's look at why not every peptide is created equal when it comes to proof.

The gold standard crowd

Some peptides have been through the ringer of clinical trials and came out with high marks. These are the ones your doctor likely knows about because they have formal approval.

• Semaglutide [Grade: A+]: This one is FDA-approved (as Wegovy and Ozempic) and has shown a 14.9% weight loss in the STEP 1 trial. It works by reducing your appetite and slowing down how fast your stomach empties.
• Tirzepatide [Grade: A+]: Also FDA-approved (Zepbound and Mounjaro), this one actually beat semaglutide in head-to-head tests, showing up to 22.5% weight loss in its primary trial.
• Tesamorelin [Grade: A]: This is FDA-approved specifically for people with HIV who have a specific type of fat gain. It can reduce visceral fat (the deep belly fat) by 18%.

The 'it depends' group

Then there are peptides that work for very specific things but might not do what the internet claims they do for general health.

For example, Thymosin Alpha-1 [Grade: A-] is approved in over 35 countries to help with the immune system, but it is not FDA-approved in the US. While it helps with things like hepatitis, using it for anti-aging is a giant question mark because the right dose hasn't been figured out yet.

The 'lost in translation' group

Some things called peptides aren't even peptides. MK-677 is actually a 'small-molecule' that you take by mouth. Even though it has been studied for years, it is not FDA-approved. It might help you gain a little bit of muscle mass, but research shows it can also raise your fasting blood sugar and worsen how your body handles insulin.

Then you have Semax, which has been used as a standard stroke treatment in Russia for over 25 years. However, in the Western world, we have very limited validation and no large clinical trials. Just because it works in one part of the world doesn't mean the data has been verified everywhere else.

Real talk about evidence gaps

Even the best-proven peptides have 'buts' attached to them:

• The Rebound: For both semaglutide and tesamorelin, the benefits often reverse or go away once you stop taking them.
• Side Effects: Semaglutide has a 'strong' signal for nausea (affecting 44% of people) and vomiting. There are even emerging reports of more serious issues like intestinal blockages.
• Missing Data: We are still waiting on long-term heart health data for tirzepatide, and we don't have enough evidence to know if tesamorelin works for general weight loss in people without HIV.

This is a great one to bring up with your doctor. You can find peptide-experienced physicians in our Find a Doctor directory.

This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.